4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-025148
Chief Commercial Officer sold 8,518 shares at an average $40.03 ($341,015)
- Chief Commercial Officer acquired 4,459 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey Chief Commercial Officer | 2022-02-16 | Option exercise | +4,259 | $24.00 | $102,216 | 4,259 | D: show line 1 in the form |
| Dierks Jeffrey Chief Commercial Officer | 2022-02-16 | Sale | −4,259 | $40.05 | $170,591 | 0 | D: show line 2 in the form |
| Dierks Jeffrey Chief Commercial Officer | 2022-02-17 | Option exercise | +200 | $24.00 | $4,800 | 200 | D: show line 3 in the form |
| Dierks Jeffrey Chief Commercial Officer | 2022-02-17 | Sale | −4,259 | $40.02 | $170,424 | 0 | D: show line 4 in the form |
| Open-market sales · 8,518 sh · avg $40.03 · $341,015 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dierks Jeffrey Chief Commercial Officer | 2022-02-16 | Option exercise · Stock Option | −4,259 | 140,597 | D: show line 5 in the form | |||||
| Dierks Jeffrey Chief Commercial Officer | 2022-02-17 | Option exercise · Stock Option | −200 | 140,397 | D: show line 6 in the form |
Loading xslF345X03/tm227120-1_4seq1.xml…